A strucutural model of the SHBG domain of human variant protein S Heerlen [1]

Thrombosis and Haemostasis

Volumn 96, Issue 4, 2006, Pages 538-540

  Nicolaes, Gerry A F ^a   Hackeng, Tilman M ^a   Segers, Kenneth ^a   Rosing, Jan ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C4 BINDING PROTEIN; PROLINE; PROTEIN S; SERINE; SEX HORMONE BINDING GLOBULIN; COMPLEMENT COMPONENT C4B BINDING PROTEIN; PROTEIN S HEERLEN;

BIOINFORMATICS; CARBOXY TERMINAL SEQUENCE; COMPUTER MODEL; GENE EXPRESSION; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; LETTER; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN S DEFICIENCY; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; SIMULATION; THROMBOSIS; WILD TYPE; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER SIMULATION; GENETICS; MUTATION; PROTEIN TERTIARY STRUCTURE;

BINDING SITES; COMPLEMENT C4B-BINDING PROTEIN; COMPUTER SIMULATION; HUMANS; MODELS, MOLECULAR; MUTATION; PROLINE; PROTEIN S; PROTEIN STRUCTURE, TERTIARY; SERINE; SEX HORMONE-BINDING GLOBULIN;

EID: 33749860118     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH06-07-0361     Document Type: Letter

References (25)

1. Bertina, RM, Ploos van Amstel HK, van Wijngaarden A, et al. Heerlen polymorphism of protein S, an immunologic polymorphism due to dimorphism of residue 460. Blood 1990; 76: 538-48.
2. Duchemin J, Gandrille S, Borgel D, et al. The Ser 460 to Pro substitution of the protein S alpha (PROS 1) gene is a frequent mutation associated with free protein S (type Ila) deficiency. Blood 1995; 86: 3436-43.
3. Giri TK, Yamazaki T, Sala N, et al. Deficient APC-cofactor activity of protein S Heerlen in degradation of factor Va Leiden: a possible mechanism of synergism between thrombophilic risk factors. Blood 2000; 96: 523-31.
4. Borgel D, Duchemin J, Alhenc-Gelas M, et al. Molecular basis for protein S hereditary deficiency: genetic defects observed in 118 patients with type I and type Ila deficiencies. The French Network on Molecular Abnormalities Responsible for Protein C and Protein S Deficiencies. J Lab Clin Med 1996; 128: 218-27.
5. Espinosa-Parrilla Y, Navarro G, Morell M, et al. Homozygosity for the protein S Heerlen allele is associated with type I PS deficiency in a thrombophilic pedigree with multiple risk factors. Thromb Haemost 2000;83:102-6.
6. Espinosa-Parrilla Y, Morell M, Souto JC, et al. Absence of linkage between type III protein S deficiency and the PROSI and C4BP genes in families carrying the protein S Heerlen allele. Blood 1997; 89: 2799-806.
7. Dahlbäck B. Purification of human C4b-binding protein and formation of its complex with vitamin K-dependent protein S. Biochem J 1983; 209: 847-56.
8. Griffin JH, Gruber A, Fernandez JA. Reevaluation of total, free, and bound protein S and C4b-binding protein levels in plasma anticoagulated with citrate or hirudin. Blood 1992; 79: 3203-11.
9. Dahlbäck B. Inhibition of protein Ca cofactor function of human and bovine protein S by C4b-binding protein. J Biol Chem 1986; 261: 12022-7.
10. van de Poel RH, Meijers JC, Bouma BN. C4b-binding protein inhibits the factor V-dependent but not the factor V-independent cofactor activity of protein S in the activated protein C-mediated inactivation of factor VIIIa. Thromb Haemost 2001; 85: 761-5.
11. Koenen RR, Gomes L, Tans G, et al. The Ser460Pro mutation in recombinant protein S Heerlen does not affect its APC-cofactor and APC-independent anticoagulant activities. Thromb Haemost 2004; 91: 1105-14.
12. Denis CV Roberts SJ, Hackeng TM, et al. In-vivo clearance of human protein S in a mouse model: influence of C4b-binding protein and the Heerlen polymorphism. Arterioscler Thromb Vase Biol 2005; 25: 2209-15.
13. Reitsma PH, Ploos van Amstel HK, Bettina RM. Three novel mutations in five unrelated subjects with hereditary protein S deficiency type 1. J Clin Invest 1994; 93: 486-92.
14. Lu D, Xie RL, Rydzewski A, et al. The effect of N-linked glycosylation on molecular weight, thrombin cleavage, and functional activity of human protein S. Thromb Haemost 1997; 77: 1156-63.
15. Giri TK, Linse S, Garcia de Frutos P, et al. Structural requirements of anticoagulant protein S for its binding to the complement regulator C4b-binding protein. J Biol Chem 2002; 277: 15099-106.
16. Kukuruzinska MA, Lennon K. Protein N-glycosylation: molecular genetics and functional significance. Crit Rev Oral Biol Med 1998; 9: 415-48.
17. Villoutreix BO, Dahlbäck B, Borgel D, et al. Three-dimensional model of the SHBG-like region of anticoagulant protein S: new structure-function insights. Proteins 2001; 43: 203-16.
18. Xiang Z, Soto CS, Honig B. Evaluating conformational free energies: the colony energy and its application to the problem of loop prediction. Proc Natl Acad Sci USA 2002; 99: 7432-7.
19. Lesk AM. Introduction to protein architecture. Oxford University Press 2001.
20. de Groot BL, van Aalten DM, Scheek RM, et al. Prediction of protein conformational freedom from distance constraints. Proteins 1997; 29: 240-51.
21. Walker FJ. Characterization of a synthetic peptide that inhibits the interaction between protein S and C4b-binding protein. J Biol Chem 1989; 264: 17645-8.
22. Nelson RM, Long GM. Binding of protein S to C4b-binding protein. Mutagenesis of protein S. J Biol Chem 1992; 267: 8140-5.
23. Fernandez JA, Heeb MJ, Griffin JH. Identification of residues 413-433 of plasmaprotein S as essential for binding to C4b-binding protein. J Biol Chem 1993; 268: 16788-94.
24. Evenäs P, Garcia De Frutos P, Linse S, et al. Both G-type domains of protein S are required for the high-affinity interaction with C4b-binding protein. Eur J Biochem 1999; 266: 935-42.
25. Anderson HA, Maylock CA, Williams JA, et al. Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells. Nat Immunol 2003; 4: 87-91.